TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 17:00 | 11/18/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | DO | P,CEO | S | -27 | 0.1998 | 0 | -135 | -100 | 0 | D | ||||||||||||||
11/4/24 17:01 | 10/31/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 17 | 15 | 131 | D | ||||||||||||||
9/12/24 17:00 | 9/10/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | DO | P,CEO | P.m | 161 | 1.61 | 0 | 100 | 444 | 123 | D | ||||||||||||||
4/2/24 16:52 | 3/31/24 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 14 | 155 | 23 | D | ||||||||||||||
11/2/23 16:51 | 10/31/23 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | O | Chief Co | M.d | 0 | 0.00 | 0 | 17 | 12 | D | |||||||||||||||
4/4/23 18:56 | 3/31/23 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chee Conley | MA | O | Chief Co | M.d | 0 | 0.00 | 0 | 2 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |